RecallRadar

FDA Drug recall D-0827-2020

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumba…

On 2020-02-12 the FDA classified a Class III recall of Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumba… by Ascend Laboratories, citing failed Dissolution Specifications: low out of specification results for dissolution testing.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0827-2020
ClassificationClass III
Statusterminated
Initiated2020-01-22
Published2020-02-12
Last updated2026-09-13 11:52 UTC
CompanyAscend Laboratories
DistributionUS

Product

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

Reason

Failed Dissolution Specifications: low out of specification results for dissolution testing.

Identifiers

ndc67877-578-14
ndc67877-578-30
ndc67877-578-01
ndc67877-578-05
ndc67877-576-14
ndc67877-576-30
ndc67877-576-01
ndc67877-576-05
ndc67877-577-14
ndc67877-577-30
ndc67877-577-01
ndc67877-577-05
ndc67877-643-14
ndc67877-643-30
ndc67877-643-01
ndc67877-643-05
ndc67877-644-14
ndc67877-644-30
ndc67877-644-01
ndc67877-644-05
ndc67877-436-14
ndc67877-436-30
ndc67877-436-01
ndc67877-436-05
ndc67877-437-14
ndc67877-437-30
ndc67877-437-01
ndc67877-437-05
ndc67877-438-14
ndc67877-438-30
ndc67877-438-01
ndc67877-438-05
code_infoLot #: 19140414, Exp 12/2020

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0827-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.